FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bupropion hydrochloride sustained-release (Bupropion HCl SR) from Actavis Pharma, Inc. under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Nicotine Dependence
• Seasonal Affective Disorder

Drugs mentioned

• Bupropion hydrochloride SR (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE)